ATE484514T1 - Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs - Google Patents

Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs

Info

Publication number
ATE484514T1
ATE484514T1 AT02805123T AT02805123T ATE484514T1 AT E484514 T1 ATE484514 T1 AT E484514T1 AT 02805123 T AT02805123 T AT 02805123T AT 02805123 T AT02805123 T AT 02805123T AT E484514 T1 ATE484514 T1 AT E484514T1
Authority
AT
Austria
Prior art keywords
derivatives
compound
isoindigo
indigo
cancer
Prior art date
Application number
AT02805123T
Other languages
English (en)
Inventor
Longgui Wang
Xiaomei Liu
Ruihuan Chen
Original Assignee
Natrogen Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/021,589 external-priority patent/US6566341B1/en
Application filed by Natrogen Therapeutics Inc filed Critical Natrogen Therapeutics Inc
Application granted granted Critical
Publication of ATE484514T1 publication Critical patent/ATE484514T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
AT02805123T 2001-12-13 2002-12-13 Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs ATE484514T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/021,589 US6566341B1 (en) 2001-12-13 2001-12-13 Derivative of isoindigo, indigo and indirubin for the treatment of cancer
US40726702P 2002-09-03 2002-09-03
PCT/US2002/039866 WO2003051900A1 (en) 2001-12-13 2002-12-13 Derivatives of isoindigo, indigo and indirubin and use in treating cancer

Publications (1)

Publication Number Publication Date
ATE484514T1 true ATE484514T1 (de) 2010-10-15

Family

ID=26694875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805123T ATE484514T1 (de) 2001-12-13 2002-12-13 Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs

Country Status (8)

Country Link
US (1) US6933315B2 (de)
EP (1) EP1458734B1 (de)
JP (1) JP2005516938A (de)
AT (1) ATE484514T1 (de)
AU (1) AU2002357191A1 (de)
CA (1) CA2469649C (de)
DE (1) DE60237993D1 (de)
WO (1) WO2003051900A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7582670B2 (en) 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US8748475B2 (en) 2004-01-12 2014-06-10 Natrogen Therapeutics International, Inc. Methods and compositions for treating lupus
US20100098702A1 (en) 2008-09-16 2010-04-22 Longgui Wang Method of treating androgen independent prostate cancer
CN101074229B (zh) * 2007-06-08 2010-09-01 无锡杰西医药科技有限公司 7-氮杂靛玉红和7-氮杂异靛蓝衍生物制备及其药学用途
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
US8563595B2 (en) * 2008-11-14 2013-10-22 Board Of Regents, The University Of Texas System Treatment of cancer with complex organic-inorganic pigment compositions
CA2868302A1 (en) * 2012-03-23 2013-09-26 Dennis M. Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
CN104602675B (zh) * 2012-06-21 2019-06-28 法斯瑞斯公司 靛玉红的奈米粒子、其衍生物以及制造和使用所述奈米粒子的方法
CN103333161B (zh) * 2013-05-28 2015-09-30 滁州市洛达生物科技有限公司 1’-氧代靛玉红的制备和用途
CA3065077C (en) 2017-05-26 2022-09-20 Taiho Pharmaceutical Co., Ltd. Novel biphenyl compound or salt thereof
DK3632443T3 (da) * 2017-05-26 2023-09-11 Taiho Pharmaceutical Co Ltd Potentiator af antitumorvirkning ved hjælp af en biphenylforbindelse
KR20210102335A (ko) * 2018-12-07 2021-08-19 나트로젠 테라퓨틱스 인터내셔널 인코포레이티드 메이소인디고의 결정다형 및 메이소인디고의 변형된 제형
US11345818B1 (en) 2020-12-29 2022-05-31 Industrial Technology Research Institute Dye for fiber and dyeing method
WO2022232243A1 (en) * 2021-04-27 2022-11-03 Curapep Llc Compositions for wound relief and inhibiting a phd protein and methods of treatment
CN114920728B (zh) * 2022-05-27 2023-10-20 中南大学 一种甲异靛衍生物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617254A (ja) * 1984-06-20 1986-01-13 Isukura Sangyo Kk ビスインドリノンおよびそれを主成分とする制癌剤
US5696092A (en) 1995-03-07 1997-12-09 George Washington University Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers
ES2194468T3 (es) * 1998-05-29 2003-11-16 Centre Nat Rech Scient Uso de derivados del bisindol indigoide para la fabricacion de un medicamento para inhibir quinasas dependientes de ciclinas.
BR0009770A (pt) * 1999-04-12 2002-01-08 Gerhard Eisenbrand Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
ATE427746T1 (de) * 1999-04-12 2009-04-15 Heinz Herbert Fiebig 5-methylindirubin zur verwendung in der behandlung von menschlichen festen tumoren

Also Published As

Publication number Publication date
CA2469649C (en) 2011-05-03
EP1458734B1 (de) 2010-10-13
DE60237993D1 (de) 2010-11-25
CA2469649A1 (en) 2003-06-26
WO2003051900A1 (en) 2003-06-26
US20040225002A1 (en) 2004-11-11
AU2002357191A1 (en) 2003-06-30
EP1458734A4 (de) 2007-12-19
US6933315B2 (en) 2005-08-23
JP2005516938A (ja) 2005-06-09
EP1458734A1 (de) 2004-09-22

Similar Documents

Publication Publication Date Title
DE60237993D1 (de) Derivate von isoindigo, indigo und indirubin und deren verwendung bei der behandlung von krebs
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
DE602004024900D1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
NO20074044L (no) Meleimidderivater, farmasoytiske preparater og fremgangsmater for behandling av kreft
IS6647A (is) Kínasólínafleiður til að meðhöndla æxli
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
DE60219954D1 (de) Neue Indol-2-on Derivate
EA200801041A1 (ru) Ингибиторы мек и способы их применения
FI913478A0 (fi) Diazinderivat.
EA200500853A1 (ru) 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
TW200744636A (en) Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
NO20004162D0 (no) Antitumor agens
EP1427418A4 (de) Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel und behandlungsverfahren
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE50109320D1 (de) Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
BRPI0511826A (pt) derivados de 2,4-diaminotiazol-5-ona
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
RU2005131723A (ru) Лечение пролиферативных заболеваний производными эпотилона и излучением
DE60305520D1 (de) 2" oxo-voruscharin und derivaten
DE60003921D1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung
RU92004439A (ru) Азотсодержащие тетрациклические соединения, способ их получения, применение и фармацевтическая композиция
TNSN05061A1 (fr) Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties